High-risk meds and safety

paper dolls holding hands
Patient safety in regard to high-risk medicines is a new focus for two organisations who have joined together to help Australian clinical pharmacists have an unprecedented opportunity to improve patient safety in the use of high-risk medicines through a new $30,000 Juno Pharmaceuticals research grant, the SHPA says. The grant has almost doubled the pool

This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.

Forgot Password?Why do I need to login & stay in?

Previous Research Roundup
Next Samoa pulls MMR vax program after infant deaths